Correction: Case series: ATRX variants in four patients with metastatic pheochromocytoma

Front Endocrinol (Lausanne). 2025 Nov 14:16:1736207. doi: 10.3389/fendo.2025.1736207. eCollection 2025.

¹ Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States.
² Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
³ Center for Cancer Research, Laboratory of Pathology, National Cancer Institute, Bethesda, MD, United States.
⁴ Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
⁵ Department of Nuclear Medicine, La Timone University Hospital & Centre de Recherches en Cancérologie de Marseille (CERIMED) & French Institute of Health and Medical Research (Inserm) UMR1068 Marseille Cancerology Research Center, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.
⁶ Developemental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Abstract

[This corrects the article DOI: 10.3389/fendo.2024.1399847.].

Keywords: ATRX; case report; imaging; pheochromocytoma; prognosis.